US Launches Drug Pricing Probe Into Germany drugs

Trump’s drug price war with Europe aims to make things cheaper for Americans

Trump administration launched a Section 301 investigation into Germany's drug pricing, arguing Germans underpay for U.S. pharmaceuticals while Americans bear higher costs.

U.S. Launches Trade Investigation Into Germany’s Drug Pricing Policies

The United States has launched a trade investigation into Germany's pharmaceutical pricing policies.

US Launches Drug Pricing Probe Into Germany drugs

EBM NEWSDESK ANALYSIS-Anthony Gill Washington has opened a Section 301 probe into German pharmaceutical pricing — the same legal tool used against China in 2018. Germany’s largest export category to the US is now squarely in the crosshairs, and the timing could hardly be worse for a transatlantic relationship already running on fumes. The Investigation Opens US Trade Representative Jamieson Greer initiated a Section 301 investigation against Ger…